Prognostic Impact of MARCO and OAS1 Expression in Metastatic Melanoma Patients Treated With Anti-PD1: a Proteomics and Transcriptomics Retrospective Analysis - Biognosys

Prognostic Impact of MARCO and OAS1 Expression in Metastatic Melanoma Patients Treated With Anti-PD1: a Proteomics and Transcriptomics Retrospective Analysis

Poster presented at ESMO 2022

 
Authors: Domenico Mallardo, Christoph Messner, Mariaelena Capone, Jakob Vowinckel, Antonio Sorrentino, Karel Novy, Vito Vanella, Kristina Beeler, Sarah Warren, Paolo Ascierto
Presenter: Domenico Mallardo (Istituto Nazionale Tumori Fondazione G Pascale, Napoli, Italy)

Date: September 10

Back to Resources overview

Helpdesk

Access our knowledge base with relevant resources and guiding information.

Contact

    Close banner

    SpectroDive™ 11

    Straightforward Validation
    of Your Protein Targets

    New: SpectroDive™ 11

    Straightforward Validation of Your Protein Targets

    learn more